Insights
Updating results
Showing results 1 - 24 of 585 Results per page:
No results found.
Explore our Insights
February 7, 2023
Charter of the French Language: Reality Check on Bill 96 and its Impacts on Trademark Use in Québec
›January 16, 2023
Chirality Matters: Dismissal of Janssen’s Judicial Review Confirms Enantiomers Are Not “Innovative Drugs” for Obtaining Data Protection
›January 12, 2023
Significant Changes to the European Patent System Are Coming in 2023 – Here is What Canadian Applicants Need to Know
›December 23, 2022
Patented Medicines Regulations: The Problem Is Not in Collecting the Data, but in How You Use It!
›December 15, 2022
Preparing the Expert Report in a Patent Case – A Collaborative Exercise to be Approached with Caution
›December 12, 2022
Getting Transparent About Transparency: Canadian Registration and Reporting of Clinical Trials
›Subscribe to our newsletter
December 6, 2022
Skating to Where the Puck Is Going to Be – How the IRAP ‘IP Assist’ Program Can Help With Startup Business Goals
›November 25, 2022
IP, Digital Identity, and Branding in the Metaverse and Web3 – Part I: Digital Identity and the Creator Economy
›November 24, 2022
70 Is the New 50: Term of Copyright Protection in Canada to Become “Life Plus 70” on December 30, 2022
›November 16, 2022
USSC Agrees to Reconsider Amgen Inc. v Sanofi on Enablement of Antibody Genus Claims
›November 2, 2022
IP Metaverse Series – Part IV: Pitching Metaverse Advertising in Canada – Opportunities and Legal Considerations
›October 21, 2022
United States Court of Appeals for the Federal Circuit Holds That an Artificial Intelligence System Cannot Be an Inventor on a Patent Application
›September 26, 2022
Form II: Anticipation and Obviousness of Crystal Form Patents in the Federal Court of Canada
›August 26, 2022
Is this Drug Safe and Effective Enough? Canadian Regulators Wade into Alzheimer’s Drug Controversy
›
Loading...
Showing results 1 - 24 of 585 Results per page:
No results found.

